Miraculins Executes Term Sheet to Acquire VeraLight’s SCOUT DS Technology

By | NEWS | No Comments

WINNIPEG, Manitoba – April 15, 2013 – Miraculins Inc. (TSX-V:MOM), (“Miraculins” or the “Company”), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, is pleased to announce that it has signed a non-binding term sheet (“Term Sheet”) with VeraLight, Inc. (“VeraLight”) to acquire all assets related to the SCOUT DS® technology, a groundbreaking diabetes screening technology that non-invasively measures changes in a person’s skin indicative of prediabetes and type 2 diabetes, enabling cost-effective, easily accessible screening of those at risk.

Gamma Medica’s LumaGem Business Acquired by Psilos Group

By | NEWS | No Comments

The LumaGEM® Molecular Breast Imaging (MBI) business of Gamma Medica, Inc. has been acquired through a chapter 11 sale by Imaging Acquisition Inc., an entity controlled by healthcare growth equity firm Psilos Group Managers, LLC. Molecular breast imaging is an adjunct technology to mammography which radiologists use to help diagnose cancerous lesions in women with dense breast tissue. Already used in 15 prestigious medical institutions and clinical practices throughout the U.S., the acquisition and investment by Psilos will enable the more focused company to meet the rapidly growing demand for LumaGEM®.

PatientSafe and Meritus Medical Center Partner to Improve Nursing Workflow and Patient Safety

By | NEWS | No Comments

PatientSafe Solutions, a leader in smart point-of-care mobile solutions, today announced it has partnered with Meritus Medical Center to implement the PatientTouch™ platform throughout the hospital. PatientTouch enhances an existing electronic medical record installation with an interoperable, PatientSafe Solutions-developed hardware and software solution that enhances patient safety, reduces waste, and improves staff productivity and satisfaction. PatientSafe and Meritus Medical Center are currently rolling out PatientTouch across the hospital’s 272-bed hospital facility in Hagerstown, Maryland.

When payers know better, they’ll do better

By | NEWS | No Comments

Maya Angelou and health insurance companies are rarely–if ever–associated with one another. But I would like to bridge that extremely wide gap and even declare that payers can learn some very important lessons from the sage poet.

“When you know better, you do better” is one of Angelou’s famous quotes. It of course applies to individuals’ personal lives, but I propose it also holds true across the health insurance industry.

AngioScore Launches New 100 mm Length AngioSculpt® Scoring Balloons For Treatment of Peripheral Artery Disease Below The Knee

By | NEWS | No Comments

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK). T

hese new AngioSculpt catheters have received U.S. Food and Drug Administration (FDA) 510(k) clearance to market for the dilatation of lesions in the iliac; femoral; iliofemoral; popliteal; infra-popliteal; and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. They are not labeled for use in the coronary or neurovasculature. Read More

Mauna Kea Technologies Announces Major Step Forward for Reimbursement of Cellvizio Optical Biopsies Performed in Ambulatory Surgery Centers

By | NEWS | No Comments

Optical biopsies added to U.S. Centers for Medicare and Medicaid Services approved procedures list

Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that Cellvizio procedures in the upper GI tract have been added to the Ambulatory Surgical Center (ASC) approved procedure list. Ambulatory Surgical Centers are health care facilities focused on providing same-day surgical care, including diagnostic and preventative services, often times found to be more convenient than hospital-based outpatient procedures. The U.S. Centers for Medicare and Medicaid Services (CMS) has approved the payment rate of $520 per previously-awarded Category 1 Current Procedural Terminology (CPT®) codes for the use of Cellvizio® during endoscopy procedures in the upper gastrointestinal tract. Read More

HealthEdge Awarded Best of Show at 2012 Healthcare IT Summit

By | NEWS | No Comments

Burlington, Mass. – Nov. 19, 2012 – HealthEdge®, provider of the only modern, enterprise-class software platform for healthcare payors, today announced that the company has won the 2012 Healthcare IT Summit XCellence “Best of Show” award. Hosted by XChange Events, the Healthcare IT Summit XCellence Awards measure information technology (IT) decision makers’ perceptions of vendor products and services, presentations and presence during the conference. Read More

Health Care Law’s Impact on Businesses Varies

By | NEWS | No Comments

WASHINGTON — Companies specializing in driving down spending on health care, whether through electronic records, preventive care or consolidating services, are turning out to be the biggest winners from the 2010 health care law.

Investors, analysts and policymakers say any business that can help health care providers cut costs or keep patients from being readmitted to the hospital soon after an in-patient visit is attracting more customers and seeing more investment. Read More